Vericel Corp (VCEL)
Biological Products, (No Diagnostic Substances) · Healthcare · $2.0B
Intrinsic Value (Consensus)
$5.53
Current Price
$38.46
Margin of Safety
-85.6%
85.6% Above Intrinsic Value
Value: $6
Price: $38
Valuation Model Estimates
Current Price: $38.46
DCF (Discounted Cash Flow)
$22.75
Graham Number
$7.08
Earnings Power Value
$3.11
Relative Value (P/E)
$6.40
Dividend Discount Model
Not applicable
—
Consensus Value
$5.53
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
62
Profitability
12/25
Strength
24/25
Valuation
7/25
Growth
19/25
Financial Health Signals
Low debt — conservative balance sheet
Strong earnings growth (20% YoY)
Key Financials
- EPS (TTM)
- $0.32
- EPS (Forward)
- $0.38
- Book Value
- $6.95
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 4.7%
- Debt/Equity
- 0%
- Revenue Growth
- 16.5%
- Earnings Growth
- 20.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance